{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:34:28Z","timestamp":1773934468743,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007091","name":"RefleXion Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.adro.2025.101940","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:57:40Z","timestamp":1764392260000},"page":"101940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-2271","authenticated-orcid":false,"given":"Tanguy","family":"Perennec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine A.","family":"Al Feghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorine","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwaseyi M.","family":"Oderinde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Gibbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Delpon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moignier","family":"Alexandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Seroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Hatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.adro.2025.101940_bib0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.adro.2025.101940_bib0002","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(02)02954-1","article-title":"Dose response in prostate cancer with 8-12 years\u2019 follow-up","volume":"54","author":"Hanks","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.adro.2025.101940_bib0003","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.adro.2025.101940_bib0004","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.02.045","article-title":"Dose escalation for prostate adenocarcinoma: a long-term update on the outcomes of a phase 3, single institution randomized clinical trial","volume":"104","author":"Pasalic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.adro.2025.101940_bib0005","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.adro.2025.101940_bib0006","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.adro.2025.101940_bib0007","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(02)02795-5","article-title":"Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning","volume":"53","author":"Cellini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101940_bib0009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1745-6215-12-255","article-title":"Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial","volume":"12","author":"Lips","year":"2011","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.adro.2025.101940_bib0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2019.11.402","article-title":"Standard and hypofractionated dose escalation to intraprostatic tumor nodules in localized prostate cancer: efficacy and toxicity in the DELINEATE trial","volume":"106","author":"Murray","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clon.2016.09.009","article-title":"Twenty fraction prostate radiotherapy with intra-prostatic boost: results of a pilot study","volume":"29","author":"Onjukka","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2019.12.044","article-title":"Evaluating the tolerability of a simultaneous focal boost to the gross tumor in prostate SABR: a toxicity and quality-of-life comparison of two prospective trials","volume":"107","author":"Alayed","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.adro.2025.101940_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"10.1016\/j.adro.2025.101940_bib0014","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S1470-2045(14)71021-6","article-title":"Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study","volume":"15","author":"Lalonde","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.adro.2025.101940_bib0015","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0016","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","article-title":"Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole","volume":"22","author":"Koh","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.adro.2025.101940_bib0017","doi-asserted-by":"crossref","first-page":"10005","DOI":"10.18632\/oncotarget.24234","article-title":"Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using 18F-fluoromisonidazole PET\/CT: a pilot study","volume":"9","author":"Supiot","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2025.101940_bib0018","first-page":"106","article-title":"The technical design and concept of a PET\/CT linac for biology-guided radiotherapy","volume":"29","author":"Oderinde","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"issue":"11","key":"10.1016\/j.adro.2025.101940_bib0019","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1109\/TMI.2012.2202322","article-title":"Comparative study with new accuracy metrics for target volume contouring in PET image guided radiation therapy","volume":"31","author":"Shepherd","year":"2012","journal-title":"IEEE Trans Med Imaging"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.adro.2025.101940_bib0021","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1109\/TMI.2008.2012036","article-title":"A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET","volume":"28","author":"Hatt","year":"2009","journal-title":"IEEE Trans Med Imaging"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0022","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijrobp.2009.08.018","article-title":"Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications","volume":"77","author":"Hatt","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.adro.2025.101940_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13638","article-title":"Treatment planning system commissioning of the first clinical biology-guided radiotherapy machine","volume":"23","author":"Simiele","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2025.101940_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-6-171","article-title":"Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications","volume":"6","author":"Wenzl","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101940_bib0025","series-title":"Tumor hypoxia","author":"Zhung","year":"2016"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0026","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101940_bib0027","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2018.12.022","article-title":"Reoxygenation during radiotherapy in intermediate-risk prostate cancer","volume":"133","author":"Supiot","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0028","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2019.09.039","article-title":"A multicenter phase 2 study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial","volume":"106","author":"Pasquier","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.adro.2025.101940_bib0029","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3109\/0284186X.2014.990109","article-title":"Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study","volume":"54","author":"Servagi-Vernat","year":"2015","journal-title":"Acta Oncol"},{"issue":"1","key":"10.1016\/j.adro.2025.101940_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.zemedi.2016.02.002","article-title":"Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study","volume":"27","author":"Thorwarth","year":"2017","journal-title":"Z Med Phys"},{"issue":"8","key":"10.1016\/j.adro.2025.101940_bib0031","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/jpm12081245","article-title":"FMISO-based adaptive radiotherapy in head and neck cancer","volume":"12","author":"Dolezel","year":"2022","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.adro.2025.101940_bib0032","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2967\/jnumed.116.188367","article-title":"Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET\/CT in patients with non-small cell lung carcinoma (RTEP5 Study)","volume":"58","author":"Vera","year":"2017","journal-title":"J Nucl Med"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:19:24Z","timestamp":1773926364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109425002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2452109425002271"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2025.101940","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2025.101940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101940"}}